Stereotactic radiofrequency ablation of subcardiac hepatocellular carcinoma: a case-control study

References

• Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391:1301–1314.
   PubMed Web of Science ®Google Scholar
• Jemal A, Ward EM, Johnson CJ, et al. Annual report to the nation on the status of cancer, 1975-2014, featuring survival. J Natl Cancer Inst. 2017;109. DOI:10.1093/jnci/djx030.
   Google Scholar
• Friedman LS. Surgery in the patient with liver disease. Trans Am Clin Climatol Assoc. 2010;121:192–204.
   PubMedGoogle Scholar
• Higgins H, Berger DL. RFA for liver tumors: does it really work? Oncologist. 2006;11:801–808.
   PubMed Web of Science ®Google Scholar
• Liver EAS, Liver EAS, Canc EORT. EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma (vol 56, pg 908, 2012). J Hepatol. 2012;56(6):1430.
   Web of Science ®Google Scholar
• Shady W, Petre EN, Gonen M, et al. Percutaneous radiofrequency ablation of colorectal cancer liver metastases: factors affecting outcomes-a 10-year experience at a single center. Radiology. 2016;278:601–611.
   PubMed Web of Science ®Google Scholar
• Kim YS, Lee WJ, Rhim H, et al. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion. Ajr. 2010;195:758–765.
   PubMed Web of Science ®Google Scholar
• Komorizono Y, Oketani M, Sako K, et al. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer. 2003;97:1253–1262.
   PubMed Web of Science ®Google Scholar
• Cha DI, Kang TW, Song KD, et al. Radiofrequency ablation for subcardiac hepatocellular carcinoma: therapeutic outcomes and risk factors for technical failure. Eur Radiol. 2019;29(5):2706–2715.
   Web of Science ®Google Scholar
• Kwan J, Appuhamy C, Lim GHT, et al. Safety and efficacy of percutaneous thermal ablation of juxta-cardiac hepatic tumours. Cardiovasc Intervent Radiol. 2018;41:920–927.
   PubMed Web of Science ®Google Scholar
• Wallach D, Toporek G, Weber S, et al. Comparison of freehand-navigated and aiming device-navigated targeting of liver lesions. Int J Med Robotics Comput Assist Surg. 2014;10:35–43.
   PubMed Web of Science ®Google Scholar
• Widmann G, Schullian P, Haidu M, et al. Targeting accuracy of CT-guided stereotaxy for radiofrequency ablation of liver tumours. Minim Invasive Ther Allied Technol. 2011;20:218–225.
   PubMed Web of Science ®Google Scholar
• Bale R, Widmann G, Haidu M. Stereotactic radiofrequency ablation. Cardiovasc Intervent Radiol. 2011;34:852–856.
   PubMed Web of Science ®Google Scholar
• Bale R, Widmann G, Schullian P, et al. Percutaneous stereotactic radiofrequency ablation of colorectal liver metastases. Eur Radiol. 2012;22:930–937.
   PubMed Web of Science ®Google Scholar
• Omary RA, Bettmann MA, Cardella JF, et al. Quality improvement guidelines for the reporting and archiving of interventional radiology procedures. J Vasc Interv Radiol. 2003;14:S293–S5.
   PubMed Web of Science ®Google Scholar
• Chen MH, Yang W, Yan K, et al. Radiofrequency ablation of problematically located hepatocellular carcinoma: tailored approach. Abdom Imaging. 2008;33:428–436.
   PubMed Web of Science ®Google Scholar
• Feng K, Yan J, Li X, et al. A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol. 2012;57:794–802.
   PubMed Web of Science ®Google Scholar
• Teratani T, Yoshida H, Shiina S, et al. Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations. Hepatology. 2006;43:1101–1108.
   PubMed Web of Science ®Google Scholar
• Shibata T, Maetani Y, Kubo T, et al. Transthoracic percutaneous radiofrequency ablation for liver tumors in the hepatic dome. J Vasc Interv Radiol. 2004;15:1323–1327.
   PubMed Web of Science ®Google Scholar
• Jin S, Fu Q, Wuyun G, et al. Management of post-hepatectomy complications. World J Gastroenterol. 2013;19:7983–7991.
   PubMed Web of Science ®Google Scholar
• Bale R, Schullian P, Eberle G, et al. Stereotactic radiofrequency ablation of hepatocellular carcinoma – a histopathological study in explanted livers. Hepatology. 2018. DOI:10.1002/hep.30406
   PubMed Web of Science ®Google Scholar
• Uehara T, Hirooka M, Ishida K, et al. Percutaneous ultrasound-guided radiofrequency ablation of hepatocellular carcinoma with artificially induced pleural effusion and ascites. J Gastroenterol. 2007;42:306–311.
   PubMed Web of Science ®Google Scholar
• de Baere T, Dromain C, Lapeyre M, et al. Artificially induced pneumothorax for percutaneous transthoracic radiofrequency ablation of tumors in the hepatic dome: initial experience. Radiology. 2005;236:666–670.
   PubMed Web of Science ®Google Scholar
• Hori T, Nagata K, Hasuike S, et al. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation. J Gastroenterol. 2003;38:977–981.
   PubMed Web of Science ®Google Scholar
• Bale R, Schullian P, Haidu M, et al. [Stereotactic radiofrequency ablation (SRFA) of intrahepatic cholangiocellular carcinomas: a minimal invasive alternative to liver resection]. Wien Med Wochenschr. 2013;163:128–131.
   PubMedGoogle Scholar
• Bale R, Richter M, Dunser M, et al. Stereotactic radiofrequency ablation for breast cancer liver metastases. J Vasc Interv Radiol. 2018;29:262–267.
   PubMed Web of Science ®Google Scholar
• Bale R, Schullian P, Schmuth M, et al. Stereotactic radiofrequency ablation for metastatic melanoma to the liver. Cardiovasc Intervent Radiol. 2016;39:1128–1135.
   PubMed Web of Science ®Google Scholar
• Ding H, Su M, Zhu C, et al. CT-guided versus laparoscopic radiofrequency ablation in recurrent small hepatocellular carcinoma against the diaphragmatic dome. Sci Rep. 2017;7:44583.
   PubMed Web of Science ®Google Scholar
• Kim SS, Kang TW, Kim M, et al. Initial radiofrequency ablation failure for hepatocellular carcinoma: repeated radiofrequency ablation versus transarterial chemoembolisation. Clin Radiol. 2018;73:216 e1–e8.
   Web of Science ®Google Scholar
• Zhou Y, Xu D, Wu L, et al. Meta-analysis of anatomic resection versus nonanatomic resection for hepatocellular carcinoma. Langenbecks Arch Surg. 2011;396:1109–1117.
   PubMed Web of Science ®Google Scholar
• Widmann G, Schullian P, Haidu M, et al. Stereotactic radiofrequency ablation (SRFA) of liver lesions: technique effectiveness, safety, and interoperator performance. Cardiovasc Intervent Radiol. 2012;35:570–580.
   PubMed Web of Science ®Google Scholar